Data as of 3:59pm ET
| -0.13 / -0.91%|
The 3 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 16.00, with a high estimate of 16.00 and a low estimate of 15.00. The median estimate represents a +12.44% increase from the last price of 14.23.
The current consensus among 5 polled investment analysts is to Hold stock in Natus Medical Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.